Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $101,685 | 36 | 53.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,753 | 4 | 19.9% |
| Travel and Lodging | $32,514 | 27 | 17.1% |
| Education | $7,961 | 2 | 4.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,603 | 1 | 1.9% |
| Food and Beverage | $3,400 | 66 | 1.8% |
| Honoraria | $3,200 | 2 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals International, Inc. | $63,842 | 11 | $0 (2019) |
| Merck Sharp & Dohme LLC | $23,352 | 18 | $0 (2022) |
| Seattle Genetics, Inc. | $19,986 | 35 | $0 (2019) |
| Millennium Pharmaceuticals, Inc. | $17,355 | 4 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $11,690 | 5 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $10,700 | 2 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $10,682 | 12 | $0 (2024) |
| Incyte Corporation | $6,150 | 5 | $0 (2022) |
| Seagen Inc. | $4,630 | 8 | $0 (2023) |
| ADC Therapeutics America, Inc. | $4,284 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,884 | 5 | AstraZeneca Pharmaceuticals LP ($2,055) |
| 2023 | $4,590 | 8 | Seagen Inc. ($4,452) |
| 2022 | $21,090 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($6,500) |
| 2021 | $4,880 | 5 | Incyte Corporation ($2,768) |
| 2020 | $10,284 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($4,200) |
| 2019 | $33,410 | 21 | Takeda Pharmaceuticals International, Inc. ($26,980) |
| 2018 | $53,988 | 31 | Takeda Pharmaceuticals International, Inc. ($23,962) |
| 2017 | $58,989 | 48 | Millennium Pharmaceuticals, Inc. ($17,355) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | PFIZER INC. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: Oncology | ||||||
| 10/26/2024 | PFIZER INC. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $85.48 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $32.07 | General |
| Category: Pacemakers | ||||||
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $2,055.00 | General |
| Category: Oncology | ||||||
| 05/15/2024 | PFIZER INC. | ADCETRIS (Biological) | Honoraria | Cash or cash equivalent | $700.00 | General |
| Category: Oncology | ||||||
| 12/11/2023 | Seagen Inc. | — | Food and Beverage | In-kind items and services | $34.94 | General |
| 11/22/2023 | Seagen Inc. | ADCETRIS (Biological) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: Oncology | ||||||
| 11/16/2023 | Seagen Inc. | ADCETRIS (Biological) | Consulting Fee | Cash or cash equivalent | $2,275.00 | General |
| Category: Oncology | ||||||
| 08/15/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Oncology | ||||||
| 06/14/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $83.50 | General |
| 06/14/2023 | Genentech USA, Inc. | Gazyva (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: BioOncology | ||||||
| 04/04/2023 | Genentech USA, Inc. | Lunsumio (Biological) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: BioOncology | ||||||
| 01/07/2023 | Seagen Inc. | — | Food and Beverage | In-kind items and services | $22.64 | General |
| 12/22/2022 | Kite Pharma, Inc. | Yescarta (Drug) | Consulting Fee | Cash or cash equivalent | $2,770.00 | General |
| Category: CELLT | ||||||
| 12/22/2022 | Kite Pharma, Inc. | Yescarta (Drug) | Travel and Lodging | In-kind items and services | $317.06 | General |
| Category: CELLT | ||||||
| 12/16/2022 | Incyte Corporation | — | Consulting Fee | Cash or cash equivalent | $615.00 | General |
| 12/10/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 12/09/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $84.79 | General |
| Category: Oncology | ||||||
| 12/09/2022 | Seagen Inc. | — | Food and Beverage | In-kind items and services | $22.47 | General |
| 12/08/2022 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $114.58 | General |
| Category: CELLT | ||||||
| 12/08/2022 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: CELLT | ||||||
| 12/01/2022 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| 08/07/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $1,883.75 | General |
| Category: Oncology | ||||||
| 07/21/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $115.88 | General |
| Category: Oncology | ||||||
| 06/27/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $6,500.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 158 | 260 | $89,529 | $22,959 |
| 2022 | 4 | 197 | 356 | $125,048 | $33,169 |
| 2021 | 4 | 175 | 311 | $109,979 | $29,826 |
| 2020 | 4 | 140 | 245 | $78,415 | $18,169 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 54 | 101 | $30,199 | $7,399 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 28 | 43 | $18,447 | $5,104 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 57 | $17,043 | $4,532 | 26.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 31 | $13,299 | $3,712 | 27.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $7,260 | $1,297 | 17.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 13 | 17 | $3,281 | $915.27 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 47 | 92 | $39,468 | $11,321 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 55 | 111 | $33,189 | $8,369 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 37 | $15,873 | $4,493 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 54 | $16,146 | $4,292 | 26.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 18 | 18 | $11,880 | $2,473 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 17 | 27 | $5,211 | $1,340 | 25.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 17 | $3,281 | $880.13 | 26.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 34 | 71 | $30,459 | $8,728 | 28.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 41 | 90 | $26,910 | $7,173 | 26.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 53 | $15,847 | $4,368 | 27.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 25 | $10,725 | $2,976 | 27.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 15 | 15 | $9,900 | $2,480 | 25.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 11 | 11 | $7,260 | $1,655 | 22.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 26 | $5,018 | $1,372 | 27.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 16 | 20 | $3,860 | $1,074 | 27.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 50 | 107 | $31,993 | $7,516 | 23.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 24 | 45 | $19,305 | $4,460 | 23.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 37 | 61 | $11,773 | $2,769 | 23.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 16 | 16 | $10,560 | $2,435 | 23.1% |
About Dr. Craig Moskowitz, MD
Dr. Craig Moskowitz, MD is a Medical Oncology healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053402503.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Craig Moskowitz, MD has received a total of $190,115 in payments from pharmaceutical and medical device companies, with $2,884 received in 2024. These payments were reported across 138 transactions from 22 companies. The most common payment nature is "Consulting Fee" ($101,685).
As a Medicare-enrolled provider, Moskowitz has provided services to 670 Medicare beneficiaries, totaling 1,172 services with total Medicare billing of $104,123. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Medical Oncology
- Other Specialties Medical Oncology
- Location Miami, FL
- Active Since 09/28/2006
- Last Updated 05/07/2018
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1053402503
Products in Payments
- ADCETRIS (Biological) $37,085
- Kazano (Drug) $26,980
- OPDIVO (Biological) $11,690
- CALQUENCE (Drug) $10,621
- SGN19A (Biological) $4,415
- ENTYVIO (Biological) $4,200
- KYMRIAH (Biological) $3,881
- Yescarta (Drug) $3,225
- UKONIQ (Drug) $2,080
- MONJUVI (Drug) $1,230
- Sprint Quattro (Device) $146.69
- BRUKINSA (Drug) $84.79
- Arctic Front (Device) $72.64
- Micra (Device) $64.16
- CareLink (Device) $55.27
- Reveal LINQ (Device) $46.05
- Claria MRI (Device) $39.75
- MICRA (Device) $32.07
- Gazyva (Biological) $31.58
- Lunsumio (Biological) $23.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Miami
Dr. Neil Love, M.d, M.D
Medical Oncology — Payments: $5.6M
Jonathan Trent, M.d., Ph. D, M.D., PH. D
Medical Oncology — Payments: $397,021
Sarbajit Mukherjee
Medical Oncology — Payments: $219,172
Orlando Silva, Md, MD
Medical Oncology — Payments: $87,713
Gilberto Lopes, Md, MD
Medical Oncology — Payments: $71,778
Dr. Guenther Koehne, M.d, M.D
Medical Oncology — Payments: $45,409